课题基金 / 基金详情

Nuclear receptor regulation of epigenetic mechanisms regulating HIV CNS latency

Nuclear receptor regulation of epigenetic mechanisms regulating HIV CNS latency
表观遗传机制的核受体调节调节HIV中枢神经系统潜伏期
批准号:
10747002
负责人:
Paula M Cannon
金额:
$74.52万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2028-05-31
关键词:
ATAC-seqAcetylationAgonistAntiinflammatory EffectAstrocytesBiological AssayBiological ModelsBrainCell MaturationCell modelCellsCentral Nervous SystemCentral Nervous System InfectionsCharacteristicsChromatin StructureClinicalCoculture TechniquesCollaborationsComplementComplexDefectDrug TargetingEnvironmentEnzymesEpigenetic ProcessEvaluationEventExhibitsFDA approvedFamilyGenetic TranscriptionGlucocorticoid ReceptorGlucocorticoidsGoalsHIVHIV InfectionsHIV-1HIV-associated neurocognitive disorderHeterogeneityHistonesHumanIL13RA1 geneIndividualInduced pluripotent stem cell derived neuronsInfectionInflammationInflammatory ResponseInterventionKnock-outLaboratoriesLeadLigandsMapsMeasuresMediatingMethodsMicrogliaModelingMolecular CloningMonitorMusNR4A2 geneNeurocognitiveNeuronsNeuropathogenesisNuclearNuclear ReceptorsOutcomePatientsPharmaceutical PreparationsPhosphorylationPhysiologyPlayPromoter RegionsRNARXRRefractoryRegulationResolutionRoleSamplingSymptomsSystemT-LymphocyteTestingTherapeuticTransformed Cell LineTransgenic MiceUnited StatesVariantVesicular stomatitis Indiana virusViralVirusVirus ReplicationWorkantiretroviral therapychromatin immunoprecipitationcohortdesigndrug candidateepigenetic regulationepigenetic silencingepigenomicsexperimental studygenetic manipulationhistone methylationhistone modificationhumanized mouseinduced pluripotent stem cellknock-downmembermouse modelneuroinflammationneurotoxicnovelnovel therapeutic interventionpharmacologicpre-clinicalprogramspromoterreactivation from latencyreceptorrecruitresponsesingle cell sequencingsingle cell technologysingle-cell RNA sequencingtranscriptometranslatable strategy

项目摘要

项目成果

Paula M Cannon的其他基金

相似基金

相关文献

中文摘要
翻译
背景。本提案题为“核受体调控的表观遗传机制调控HIV中枢神经系统”
英文摘要
Background. This proposal entitled “"Nuclear receptor regulation of epigenetic mechanisms regulating HIV CNS latency" is submitted in response to RFA-MH-22-280: Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies”. Microglial cells are the main target of HIV infection in the central nervous system (CNS) and form a reservoir of infection that persists despite antiviral treatment and contributes to HIV-associated neurocognitive disorder (HAND). Our goal. Using microglia cellular models, we demonstrated previously that the Nurr1 nuclear receptor, working in conjunction with ligand-activated nuclear receptors, plays a critical role in the regulation of HIV latency. We confirmed these observations in iPSC-derived human microglia (iMG), which provide the most informative primary cell model to study the interaction between HIV and this important target cell. Here, we will test the hypothesis that agonists of the Nurr1, RXR and RAR nuclear receptors lead to HIV silencing, suggesting a novel therapeutic strategy for HIV infections in the CNS. Underpinning this work are two key technical advances allowing the study of HIV in human microglia. First, we now have the capability to study HIV latency using iMG alone or in combination with iPSC-derived neurons and astrocytes - the first available model systems that do not rely on transformed cell lines. Second, in collaboration with the Cannon laboratory, we established a humanized mouse model of HIV latency in microglia based on the new NOG-hIL34 transgenic mouse, which is We demonstrated that the humanized mice support latent HIV infection of human microglia. We have been able to identify latently infected cells recovered from the humanized mice. In addition, we applied single cell RNA sequencing (scRNA-Seq) to confirm that the microglia have transcriptional characteristics that match reference human microglia and further identified subsets of reactive microglial cells that are associated with active HIV infections. the only humanized mouse model to support full human microglial cell maturation. Using these models, we will apply highly sensitive chromatin immunoprecipitation (ChIP) and single cell sequencing and epigenomics analyses to define nuclear receptor interactions with the HIV promoter region, and the mechanism of epigenetic silencing on the HIV LTR. How will we advance the field? Numerous clinically-effective, brain-penetrant drugs that regulate the nuclear receptors are available, many of which are now FDA approved, and will be evaluated using the iPSC derived cell models and in the humanized mouse model for their impact on HIV expression and latency in the context of an intact brain. We are undertaking these technically challenging studies because it is only by working within the context of authentic human microglial cells and an environment that better reflects the HIV-infected CNS, that the underlying physiology is accurately represented. We believe these studies will allow us to obtain a convincing proof-of-concept for this important therapeutic strategy to target HIV CNS Latency and Neuropathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene edited B cells to co-express CNS-targeted antibodies
Gene edited B cells to co-express CNS-targeted antibodies
Combination gene editing for local and systemic HIV resistance
Novel hematopoietic stem cell engineering and transplantation approaches for HIV cure
  • 批准号:
    10163906
  • 项目类别:
  • 资助金额:
    $265.82万
  • 财政年份:
    2020
  • 负责人:
    Paula M Cannon
  • 依托单位:
海外基金